Rezultati - Suresh C. Jhanwar
- Showing 1 - 20 results of 27
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy-Induced Apoptosis of <i>p53</i>-Mutated Multiple Myeloma Cells od Heather Landau, Samuel McNeely, Jayasree S. Nair, Raymond L. Comenzo, Takashi Asai, Hillel Friedman, Suresh C. Jhanwar, Stephen D. Nimer, Gary K. Schwartz
Izdano 2012Artigo -
10
-
11
-
12
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element od James C. Mulloy, Jörg Cammenga, Francisco J. Berguido, Kaida Wu, Ping Zhou, Raymond L. Comenzo, Suresh C. Jhanwar, Malcolm A.S. Moore, Stephen D. Nimer
Izdano 2003Artigo -
13
The <i>NF2</i> Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression od Guang‐Hui Xiao, Ryan J. Gallagher, Justin N Shetler, Kristine L. Skele, Deborah A. Altomare, Richard G. Pestell, Suresh C. Jhanwar, Joseph R. Testa
Izdano 2005Artigo -
14
Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling od Xiaoliang L. Xu, Yuqiang Fang, Thomas C. Lee, Douglas Forrest, Cheryl Y. Gregory‐Evans, Dena Almeida, Aihong Liu, Suresh C. Jhanwar, David H. Abramson, David Cobrinik
Izdano 2009Artigo -
15
-
16
IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma od Daniel Gorovets, Kasthuri Kannan, Ronglai Shen, Edward R. Kastenhuber, Nasrin Islamdoust, Carl Campos, Elena Pentsova, Adriana Heguy, Suresh C. Jhanwar, Ingo K. Mellinghoff, Timothy A. Chan, Jason T. Huse
Izdano 2012Artigo -
17
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide od Steven L. Soignet, P. Maslak, Zhugang Wang, Suresh C. Jhanwar, Elizabeth Calleja, Laura J. Dardashti, Diane Corso, A DeBlasio, Janice Gabrilove, David A. Scheinberg, Pier Paolo Pandolfi, Raymond P. Warrell
Izdano 1998Artigo -
18
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response od Nicholas J. Szerlip, Alicia Pedraza, Debyani Chakravarty, M. G. Shahrul Azim, Jeremy McGuire, Yuqiang Fang, Tatsuya Ozawa, Eric C. Holland, Jason T. Huse, Suresh C. Jhanwar, Margaret Leversha, Tom Mikkelsen, Cameron Brennan
Izdano 2012Artigo -
19
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation od Gunjan L. Shah, Heather Landau, Dory Londono, Sean M. Devlin, Satyajit Kosuri, Alexander M. Lesokhin, Nikoletta Lendvai, Hani Hassoun, David J. Chung, Guenther Koehne, Suresh C. Jhanwar, Ola Landgren, Ross L. Levine, Sergio Giralt
Izdano 2017Artigo -
20
Rearrangement of the bcl-6 Gene as a Prognostic Marker in Diffuse Large-Cell Lymphoma od Kenneth Offit, Francesco Lo‐Coco, Diane C. Louie, Nasser Z. Parsa, Denis H. Y. Leung, Carol S. Portlock, Bihui H. Ye, Florigio Lista, Daniel A. Filippa, Ayala Rosenbaum, Marc Ladanyi, Suresh C. Jhanwar, Riccardo Dalla-Favera, R.S.K. Chaganti
Izdano 1994Artigo
Iskalna orodja:
Sorodne teme
Biology
Gene
Genetics
Cancer research
Medicine
Internal medicine
Pathology
Cancer
Biochemistry
Molecular biology
Cell biology
Immunology
Allele
Carcinogenesis
Cell cycle
Chromosome
Gastroenterology
Mutation
Oncology
Apoptosis
Cell
Cell culture
Chemotherapy
DNA
KRAS
Leukemia
Loss of heterozygosity
Multiple myeloma
Receptor
Stem cell